Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-09-15 Purchase | 2023-09-28 06:15 am | OKYO Pharma Ltd | OKYO | BRANCACCIO JOHN P Director | 16,670 | $1.5 | $25,005 | 16,670 (Direct) | View |
| 2022-05-19 Purchase | 2022-05-20 10:35 am | OKYO Pharma Ltd | OKYO | CERRONE GABRIELE M Executive Chairman | 5,800,000 | $0.076 | $440,800 | 548,981,215 (Indirect) | View |
| 2022-05-17 Purchase | 2022-05-18 11:37 am | OKYO Pharma Ltd | OKYO | CERRONE GABRIELE M Non-Executive Chairman 10% Owner | 1,625,000 | $0.0595 | $96,688 | 544,806,215 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-10-23 Other | 2023-10-31 4:15 pm | N/A N/A | OKYO Pharma Ltd | OKYO | CERRONE GABRIELE M Executive Chairman | 569,539 | $1.5 | 9,747,442 (Indirect) | View |
Ownership | 2022-05-16 5:53 pm | N/A 2028-08-19 | OKYO Pharma Ltd | OKYO | Shah Keeren Chief Financial Officer | 0 | $0 | 950,000 (Direct) | View |
Ownership | 2022-05-16 5:52 pm | N/A 2025-06-07 | OKYO Pharma Ltd | OKYO | Simon Willy Jules Director | 0 | $0 | 2,000,000 (Direct) | View |
Ownership | 2022-05-16 5:47 pm | N/A 2028-08-19 | OKYO Pharma Ltd | OKYO | BRANCACCIO JOHN P Director | 0 | $0 | 1,450,000 (Direct) | View |
Ownership | 2022-05-16 5:44 pm | N/A 2029-01-06 | OKYO Pharma Ltd | OKYO | JACOB GARY S Chief Executive Officer | 0 | $0 | 53,000,000 (Direct) | View |
Ownership | 2022-05-16 5:41 pm | N/A N/A | OKYO Pharma Ltd | OKYO | CERRONE GABRIELE M Executive Chairman 10% Owner | 0 | $0 | 543,181,215 (Indirect) | View |
Ownership | 2022-05-16 5:37 pm | N/A 2032-01-31 | OKYO Pharma Ltd | OKYO | Denoyer Bernard Director | 0 | $0 | 1,000,000 (Direct) | View |